subgroup of
drug)
→
ReceivesAction
→
developed by amgen
| Typicality: | 0.250 |
| Saliency: | 0.000 |
| new drug → be developed by → amgen | 3 |
| negative | neutral | positive |
| 0.008 | 0.506 | 0.487 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 35.970 |